Cargando…

Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study

BACKGROUND: Advanced stage cervical cancer is primarily treated by radiotherapy. Local tumor control is a prerequisite for cure. Imaging after treatment is controversial. Positron emission tomography (PET) combined with computer tomography (PET-CT) shows great promise for detecting metastases. On th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mongula, J. E., Bakers, F. C. H., Vöö, S., Lutgens, L., van Gorp, T., Kruitwagen, R. F. P. M., Slangen, B. F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748389/
https://www.ncbi.nlm.nih.gov/pubmed/29292485
http://dx.doi.org/10.1186/s13550-017-0352-6
_version_ 1783289387874779136
author Mongula, J. E.
Bakers, F. C. H.
Vöö, S.
Lutgens, L.
van Gorp, T.
Kruitwagen, R. F. P. M.
Slangen, B. F. M.
author_facet Mongula, J. E.
Bakers, F. C. H.
Vöö, S.
Lutgens, L.
van Gorp, T.
Kruitwagen, R. F. P. M.
Slangen, B. F. M.
author_sort Mongula, J. E.
collection PubMed
description BACKGROUND: Advanced stage cervical cancer is primarily treated by radiotherapy. Local tumor control is a prerequisite for cure. Imaging after treatment is controversial. Positron emission tomography (PET) combined with computer tomography (PET-CT) shows great promise for detecting metastases. On the other hand, magnetic resonance imaging (MRI) is superior in depicting anatomical details. The combination of PET-MRI could result in more accurate evaluation of cervical cancer treatment outcome. The aim of this pilot study is to share our initial experience with PET-MRI in the evaluation of treatment response in cervical cancer after radiation treatment. METHODS: Ten patients with cervical carcinoma (FIGO ≥IB2) were prospectively evaluated. Eleven weeks (median; range 8–15 weeks) after radiation therapy, treatment response was evaluated by PET-MRI. The PET, MRI, and combined PET-MRI images were evaluated for the presence of local residual tumor and metastasis. Diagnostic performance was assessed by area under the receiver operator characteristic (ROC) curve for evaluation of local residual tumor. The readers were blinded for outcome data. Local residual disease, metastasis, diagnostic confidence, and change of opinion were scored on a 5-point Likert scale. The reference standard consisted of pathology and/or follow-up according to the clinical guidelines. RESULTS: Three out of ten patients had local residual abnormalities suggestive for tumor residue after radiation treatment. The availability of both PET and MRI resulted in an increase in diagnostic confidence in 80–90% of all patients. Change of opinion was observed in 70% and change of policy in 50%, especially in the group with residual tumor. The diagnostic accuracy increased significantly for the radiologist if PET-MRI was combined (AUC .54 versus .83). CONCLUSIONS: PET-MRI shows promise for evaluation of treatment response after radiation for cervical cancer, especially increasing diagnostic confidence, while potentially increasing diagnostic performance.
format Online
Article
Text
id pubmed-5748389
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-57483892018-01-20 Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study Mongula, J. E. Bakers, F. C. H. Vöö, S. Lutgens, L. van Gorp, T. Kruitwagen, R. F. P. M. Slangen, B. F. M. EJNMMI Res Preliminary Research BACKGROUND: Advanced stage cervical cancer is primarily treated by radiotherapy. Local tumor control is a prerequisite for cure. Imaging after treatment is controversial. Positron emission tomography (PET) combined with computer tomography (PET-CT) shows great promise for detecting metastases. On the other hand, magnetic resonance imaging (MRI) is superior in depicting anatomical details. The combination of PET-MRI could result in more accurate evaluation of cervical cancer treatment outcome. The aim of this pilot study is to share our initial experience with PET-MRI in the evaluation of treatment response in cervical cancer after radiation treatment. METHODS: Ten patients with cervical carcinoma (FIGO ≥IB2) were prospectively evaluated. Eleven weeks (median; range 8–15 weeks) after radiation therapy, treatment response was evaluated by PET-MRI. The PET, MRI, and combined PET-MRI images were evaluated for the presence of local residual tumor and metastasis. Diagnostic performance was assessed by area under the receiver operator characteristic (ROC) curve for evaluation of local residual tumor. The readers were blinded for outcome data. Local residual disease, metastasis, diagnostic confidence, and change of opinion were scored on a 5-point Likert scale. The reference standard consisted of pathology and/or follow-up according to the clinical guidelines. RESULTS: Three out of ten patients had local residual abnormalities suggestive for tumor residue after radiation treatment. The availability of both PET and MRI resulted in an increase in diagnostic confidence in 80–90% of all patients. Change of opinion was observed in 70% and change of policy in 50%, especially in the group with residual tumor. The diagnostic accuracy increased significantly for the radiologist if PET-MRI was combined (AUC .54 versus .83). CONCLUSIONS: PET-MRI shows promise for evaluation of treatment response after radiation for cervical cancer, especially increasing diagnostic confidence, while potentially increasing diagnostic performance. Springer Berlin Heidelberg 2018-01-02 /pmc/articles/PMC5748389/ /pubmed/29292485 http://dx.doi.org/10.1186/s13550-017-0352-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Preliminary Research
Mongula, J. E.
Bakers, F. C. H.
Vöö, S.
Lutgens, L.
van Gorp, T.
Kruitwagen, R. F. P. M.
Slangen, B. F. M.
Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study
title Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study
title_full Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study
title_fullStr Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study
title_full_unstemmed Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study
title_short Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study
title_sort positron emission tomography-magnetic resonance imaging (pet-mri) for response assessment after radiation therapy of cervical carcinoma: a pilot study
topic Preliminary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748389/
https://www.ncbi.nlm.nih.gov/pubmed/29292485
http://dx.doi.org/10.1186/s13550-017-0352-6
work_keys_str_mv AT mongulaje positronemissiontomographymagneticresonanceimagingpetmriforresponseassessmentafterradiationtherapyofcervicalcarcinomaapilotstudy
AT bakersfch positronemissiontomographymagneticresonanceimagingpetmriforresponseassessmentafterradiationtherapyofcervicalcarcinomaapilotstudy
AT voos positronemissiontomographymagneticresonanceimagingpetmriforresponseassessmentafterradiationtherapyofcervicalcarcinomaapilotstudy
AT lutgensl positronemissiontomographymagneticresonanceimagingpetmriforresponseassessmentafterradiationtherapyofcervicalcarcinomaapilotstudy
AT vangorpt positronemissiontomographymagneticresonanceimagingpetmriforresponseassessmentafterradiationtherapyofcervicalcarcinomaapilotstudy
AT kruitwagenrfpm positronemissiontomographymagneticresonanceimagingpetmriforresponseassessmentafterradiationtherapyofcervicalcarcinomaapilotstudy
AT slangenbfm positronemissiontomographymagneticresonanceimagingpetmriforresponseassessmentafterradiationtherapyofcervicalcarcinomaapilotstudy